| Autor: |
Hallas J; Syddansk Universitet, Afdelingen for Klinisk Farmakologi, IST, Forskningsenheden for almen medicin, Odense. jhallas@health.sdu.dk, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen AT |
| Jazyk: |
dánština |
| Zdroj: |
Ugeskrift for laeger [Ugeskr Laeger] 2007 Apr 23; Vol. 169 (17), pp. 1577-9. |
| Abstrakt: |
The clinical use of anti-thrombotic agents has shifted towards more aggressive therapy and towards regimes with more than one drug. Data on the risk of upper gastrointestinal bleedings (UGB) with combined anti-thrombotic therapy are scarce. In the period 2000 through 2004, 1,443 cases of serious UGB and 57,720 control subjects were identified in Funen County. Anti-thrombotic therapy is becoming increasingly aggressive. Combined anti-thrombotic therapy confers particular risk and is associated with high incidence rates of GI bleeding. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
